Cornerstone Advisory, LLC Abb Vie Inc. Transaction History

Cornerstone Advisory, LLC

$720 Million
Q3 2024

A detailed history of Cornerstone Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cornerstone Advisory, LLC holds 15,586 shares of ABBV stock, worth $2.74 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

15,586

Previous 15,987 2.51%

Holding current value

$2.74 Million

Previous $2.74 Million 12.22%

% of portfolio

0.43%

Previous 0.4%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $65,699 - $79,931	-401 Reduced 2.51%	15,586 $3.08 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $795,156 - $928,564	-5,137 Reduced 24.32%	15,987 $2.74 Million
Q1 2024 May 08, 2024	BUY	$159.82 - $182.1 $2,557 - $2,913	16 Added 0.08%	21,124 $3.85 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $109,392 - $123,201	795 Added 3.91%	21,108 $3.27 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $12,557 - $14,537	94 Added 0.46%	20,313 $3.03 Million
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $32,332 - $40,235	-244 Reduced 1.19%	20,219 $2.72 Million
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $260,008 - $299,438	1,798 Added 9.63%	20,463 $3.26 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $206,773 - $247,975	-1,495 Reduced 7.42%	18,665 $3.02 Million
Q3 2022 Oct 26, 2022	BUY	$134.21 - $153.93 $306,133 - $351,114	2,281 Added 12.76%	20,160 $2.71 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $2.04 Million - $2.6 Million	-14,850 Reduced 45.37%	17,879 $2.74 Million
Q1 2022 May 20, 2022	SELL	$131.98 - $163.75 $791 - $982	-6 Reduced 0.02%	32,729 $5.31 Million
Q4 2021 Feb 23, 2022	SELL	$107.43 - $135.93 $7,842 - $9,922	-73 Reduced 0.22%	32,735 $4.43 Million
Q3 2021 Nov 16, 2021	SELL	$106.4 - $120.78 $65,861 - $74,762	-619 Reduced 1.85%	32,808 $3.54 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $356,030 - $396,638	3,384 Added 11.26%	33,427 $3.77 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $192,426 - $211,838	-1,881 Reduced 5.89%	30,043 $3.25 Million
Q4 2020 May 11, 2021	BUY	$80.49 - $108.67 $102,302 - $138,119	1,271 Added 4.15%	31,924 $3.42 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $1.66 Million - $1.95 Million	19,374 Added 171.77%	30,653 $2.69 Million
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $434,863 - $581,912	5,927 Added 110.74%	11,279 $1.11 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $345,204 - $523,372	5,352 New	5,352 $408,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisory, LLC with notifications on news.

Account

Cornerstone Advisory, LLC Abb Vie Inc. Transaction History